| A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction (NCT00663767) | Pfizer | 2008-04-07 |
| PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia (NCT00614705) | Pfizer | 2008-04-01 |
| Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects (NCT00694044) | Pfizer | 2008-04-01 |
| Study Of Sunitinib With Capecitabine In Breast Cancer (NCT00662025) | Pfizer | 2008-04-01 |
| Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug (NCT00645021) | Pfizer | 2008-04-01 |
| A Double-blind, Parallel Group, Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep (NCT00655369) | Pfizer | 2008-04-01 |
| Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan). (NCT00716820) | Pfizer | 2008-04-01 |
| A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. (NCT00600821) | Pfizer | 2008-04-01 |
| Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (NCT00662831) | Pfizer | 2008-04-01 |
| Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking (NCT00594204) | Pfizer | 2008-04-01 |
| Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology (NCT00596830) | Pfizer | 2008-04-01 |
| Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus (NCT00637338) | Pfizer | 2008-04-01 |
| A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1) (NCT00658008) | Pfizer | 2008-04-01 |
| Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus. (NCT00671671) | Pfizer | 2008-04-01 |
| Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug (NCT00644839) | Pfizer | 2008-04-01 |
| Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects (NCT00631371) | Pfizer | 2008-04-01 |
| Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke (NCT03860506) | Pfizer | 2008-04-01 |
| Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan (NCT00661661) | Pfizer | 2008-04-01 |
| Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer (NCT00609622) | Pfizer | 2008-04-01 |
| A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers. (NCT00661765) | Pfizer | 2008-04-01 |
| Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis (NCT00641225) | Pfizer | 2008-03-31 |
| A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia (NCT00637052) | Pfizer | 2008-03-18 |
| An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis (NCT00601484) | Pfizer | 2008-03-17 |
| A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen (NCT00615056) | Pfizer | 2008-03-01 |
| Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®) (NCT00617760) | Pfizer | 2008-03-01 |
| Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza (NCT00640042) | Pfizer | 2008-03-01 |
| A Study Of Early Markers Of Choroidal Neovascularization (NCT00902785) | Pfizer | 2008-03-01 |
| Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors (NCT00560235) | Pfizer | 2008-03-01 |
| Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice. (NCT00858208) | Pfizer | 2008-03-01 |
| Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis (NCT00634933) | Pfizer | 2008-03-01 |
| A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate (NCT00620685) | Pfizer | 2008-03-01 |
| Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis (NCT00565409) | Pfizer | 2008-03-01 |
| Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury (NCT00555009) | Pfizer | 2008-03-01 |
| A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test (NCT00763204) | Pfizer | 2008-02-29 |
| Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR] (NCT00700258) | Pfizer | 2008-02-13 |
| Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML (NCT00574873) | Pfizer | 2008-02-05 |
| Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer (NCT00553254) | Pfizer | 2008-02-05 |
| Genotropin Treatment In Very Young Children Born Small For Gestational Age (NCT00627523) | Pfizer | 2008-02-01 |
| Bioequivalence Study Of Verapamil (NCT00668967) | Pfizer | 2008-02-01 |
| Effect of PF-00734200 in Subjects With Type 2 Diabetes (NCT00618007) | Pfizer | 2008-02-01 |
| Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554 (NCT00651027) | Pfizer | 2008-02-01 |
| Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration. (NCT00820742) | Pfizer | 2008-02-01 |
| Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder. (NCT00611026) | Pfizer | 2008-02-01 |
| This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis (NCT00548262) | Pfizer | 2008-02-01 |
| Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan (NCT00757575) | Pfizer | 2008-02-01 |
| Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder. (NCT00658684) | Pfizer | 2008-02-01 |
| A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD). (NCT00559910) | Pfizer | 2008-02-01 |
| A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease (NCT00607308) | Pfizer | 2008-02-01 |
| Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib. (NCT00484718) | Pfizer | 2008-01-17 |
| Transthyretin Amyloidosis Outcome Survey (THAOS) (NCT00628745) | Pfizer | 2008-01-04 |
| Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer (NCT00631410) | Pfizer | 2008-01-01 |
| An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma. (NCT00555906) | Pfizer | 2008-01-01 |
| Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan (NCT00603512) | Pfizer | 2008-01-01 |
| ACTiF- Assessment of Closed Tibial Fractures (NCT00533377) | Pfizer | 2008-01-01 |
| Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones (NCT00576589) | Pfizer | 2008-01-01 |
| A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease (NCT00615199) | Pfizer | 2008-01-01 |
| Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients (NCT00676143) | Pfizer | 2008-01-01 |
| Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer (NCT00603538) | Pfizer | 2008-01-01 |
| Anidulafungin In Treatment Of Candidemia In Asian Subjects (NCT00537329) | Pfizer | 2008-01-01 |
| Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study (NCT00793403) | Pfizer | 2008-01-01 |
| Registry For Patients Treated With BeneFix In Usual Care Setting In Germany (NCT00714415) | Pfizer | 2008-01-01 |
| Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors (NCT00879684) | Pfizer | 2008-01-01 |
| A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients (NCT00483171) | Pfizer | 2008-01-01 |
| Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD) (NCT00730665) | Pfizer | 2008-01-01 |
| RN624 For Pain Of Post-Herpetic Neuralgia (NCT00568321) | Pfizer | 2007-12-19 |
| Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC) (NCT00569946) | Pfizer | 2007-12-12 |
| Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. (NCT00572455) | Pfizer | 2007-12-11 |
| Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus (NCT00502242) | Pfizer | 2007-12-01 |
| A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia. (NCT00612170) | Pfizer | 2007-12-01 |
| Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias (NCT00811070) | Pfizer | 2007-12-01 |
| A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge (NCT00562120) | Pfizer | 2007-12-01 |
| Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII (NCT00543439) | Pfizer | 2007-12-01 |
| Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization (NCT00508742) | Pfizer | 2007-12-01 |
| A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease (NCT00566397) | Pfizer | 2007-12-01 |
| A Study Of PF-03732010 In Patients With Advanced Solid Tumors (NCT00557505) | Pfizer | 2007-12-01 |
| A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight (NCT00542009) | Pfizer | 2007-12-01 |
| Study Evaluating Vabicaserin in Subjects With Schizophrenia (NCT00563706) | Pfizer | 2007-12-01 |
| Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments (NCT00560560) | Pfizer | 2007-12-01 |
| A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy. (NCT00625833) | Pfizer | 2007-12-01 |
| A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD). (NCT00531752) | Pfizer | 2007-12-01 |
| A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test (NCT00762658) | Pfizer | 2007-11-30 |
| A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction (NCT00542035) | Pfizer | 2007-11-11 |
| A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia (NCT00567203) | Pfizer | 2007-11-01 |
| Fesoterodine "add-on" Male Overactive Bladder Study (NCT00546637) | Pfizer | 2007-11-01 |
| Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease (NCT00498602) | Pfizer | 2007-11-01 |
| A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors (NCT00557856) | Pfizer | 2007-11-01 |
| A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee (NCT00565812) | Pfizer | 2007-11-01 |
| Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer (NCT00553696) | Pfizer | 2007-11-01 |
| Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL) (NCT00562965) | Pfizer | 2007-11-01 |
| Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer (NCT00560573) | Pfizer | 2007-11-01 |
| A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life. (NCT00549055) | Pfizer | 2007-11-01 |
| Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder. (NCT00561951) | Pfizer | 2007-11-01 |
| Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets (NCT01089582) | Pfizer | 2007-11-01 |
| Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis (NCT00759161) | Pfizer | 2007-11-01 |
| Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder. (NCT00562055) | Pfizer | 2007-11-01 |
| Varenicline Observational Investigation In The Cessation of Smoking (NCT00669240) | Pfizer | 2007-11-01 |
| Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia (NCT00580125) | Pfizer | 2007-11-01 |
| A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste (NCT00762151) | Pfizer | 2007-11-01 |
| Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo (NCT00570063) | Pfizer | 2007-11-01 |
| CP-690,550 Thorough QTc Study (NCT01743677) | Pfizer | 2007-10-26 |